Notice of 34th Annual General Meeting of Vista Pharmaceuticals Limited to be held on Tuesday 30th September 2025
34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
- Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
- Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
Later from Vista Pharmaceuticals
- Reg. 34 (1) Annual Report.
- Intimation Of Book Closure Regarding 34" Annual General Meeting
- Vista Pharmaceuticals Ltd. Press Release Sep 08 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Vista Pharmaceuticals Ltd. Press Release Sep 09 2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals